US 11638761
Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 11638761 (Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy) held by Dyne Therapeutics, Inc. expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Dyne Therapeutics, Inc.
- Grant date
- Tue May 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K38/00, A61K47/6807